Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine

By Bruhl P.   Kerschbaum A.   Kistner O.   Barrett N.   Dorner F.   Gerencer M.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1149-1158

Elsevier

Access to resources Recommend Favorite

Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells

By Choi Y.   Ahn C.-J.   Seong K.-M.   Jung M.-Y.   Ahn B.-Y.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1867-1873

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

By Tree J.A.   Richardson C.   Fooks A.R.   Clegg J.C.   Looby D.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3444-3450

Elsevier

Access to resources Recommend Favorite

Characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate

By Lin Y.-C.   Wu C.-N.   Shih S.-R.   Ho M.-S.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2485-2493

Elsevier

Access to resources Recommend Favorite